Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InMed Pharmaceuticals (INM) Non Operating Income (2020 - 2024)

InMed Pharmaceuticals has reported Non Operating Income over the past 2 years, most recently at $528120.0 for Q2 2024.

  • For Q2 2024, Non Operating Income rose 7.2% year-over-year to $528120.0; the TTM value through Jun 2024 reached $1.1 million, changed N/A, while the annual FY2024 figure was $527901.0, 7.2% up from the prior year.
  • Non Operating Income for Q2 2024 was $528120.0 at InMed Pharmaceuticals, up from $102987.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $528120.0 in Q2 2024 and troughed at -$70.0 in Q1 2023.